Response and resistance to BET bromodomain inhibitors in triple-negative breast cancerShaokun Shu, Kornélia Polyák, Charles Y. Lin et al.|Nature|2016Cited by 629
Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid MalignanciesRomain Guièze, Catherine J. Wu, Elisa ten Hacken et al.|Cancer Cell|2019Cited by 361
Functional TRIM24 degrader via conjugation of ineffectual bromodomain and VHL ligandsLara Gechijian, James E. Bradner, Dennis L. Buckley et al.|Nature Chemical Biology|2018Cited by 229
Selective targeting of MYC mRNA by stabilized antisense oligonucleotidesTaylor Gill, Christopher J. Ott|Oncogene|2021Cited by 16
DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional ReprogrammingIlaria Gritti, Nabeel Bardeesy, Jinkai Wan et al.|Cancer Discovery|2024Cited by 14